Modern possibilities of using oral anticoagulant practice in the practice of a primary care physician
Atrial fibrillation (AF) significantly increases the risk of thromboembolic complications in these patients, and therefore, preventive measures in the form of anticoagulant therapy are of paramount importance. In accordance with the current recommendations of the European Society of Cardiology, anticoagulant therapy should be prescribed to all patients with AF and a CHA2DS2-VASc index ≥ 2. In the presence of at least one clinical risk factor for stroke (CHA2DS2-VASc index value ≥ 1 for men and ≥ 2 for women) Consideration should be given to prescribing direct oral anticoagulants (DOCs), which are recommended as first-line drugs in patients with non-valvular AF. Even if the patient is already receiving a vitamin K antagonist (AVK), it can be replaced by a POAC The article presents data on the feasibility of using POAC, including apixaban (Eliquis), which has high efficiency, safety, and ease of use.